申请人:Amgen Inc.
公开号:US20200055845A1
公开(公告)日:2020-02-20
Provided herein are methods of using KRAS G12C inhibitors and compositions of the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.